NCT01598740
Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease
See it on ClinicalTrials.gov ↗18 people
27.8%
72.2%
5 womenmiddle line = equal numbers13 men
- Phase
- PHASE1
- Paid for by
- Sorbent Therapeutics
- Finished
- 2012-09
- Health conditions
- Heart Failure
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 59.9 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
No rules that kept women out were found.
Study titles and rules are shown in their original English.